Catatonia is not schizophrenia and it is treatable

被引:8
作者
Appiani, Francisco J. [1 ]
Castro, Gonzalo S. [2 ]
机构
[1] Univ Buenos Aires, Hosp Clin Jose de San Martin, Direct Teaching & Res, Program Pharmacol, Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Hosp Clin Jose de San Martin, Program Abnormal Movements & Parkinson Dis, Neurol Div,Fellowship Abnormal Movements, Buenos Aires, DF, Argentina
关键词
Catatonia; Lorazepam; Electroconvulsive therapy;
D O I
10.1016/j.schres.2017.05.030
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Catatonia is a cluster of motor features that appears in many recognized psychiatric illnesses, that according to the DSM-5 it is not linked as a subtype to schizophrenia anymore. The classic signs are mutism, a rigid posture, fixed staring, stereotypic movements, and stupor, which are all part of a broad psychopathology that may be found in affective, thought, neurological, toxic, metabolic and immunological disorders. Despite the many etiologies, catatonia may be a life-threatening condition with a specific treatment. Benzodiazepines are the first line therapeutic option for catatonia, being lorazepam the first-choice drug. Eighty percent of the patients are relieved by the use of barbiturates or benzodiazepines, while in those who fail, an improvement is achieved by electroconvulsive therapy (ECT). With more than 60 years of use in catatonic patients, ECT has proven to be an effective and safe tool for the treatment of this frequent and sometimes forgotten syndrome. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:112 / 116
页数:5
相关论文
共 63 条
  • [51] One-year outcome after response to ECT in middle-aged and elderly patients with intractable catatonic schizophrenia
    Suzuki, K
    Awata, S
    Matsuoka, H
    [J]. JOURNAL OF ECT, 2004, 20 (02) : 99 - 106
  • [52] Diminished ECT response in catatonia due to chronic neurologic condition
    Swartz, CM
    Acosta, D
    Bashir, A
    [J]. JOURNAL OF ECT, 2003, 19 (02) : 110 - 114
  • [53] THE INFLUENCE OF KARL KLEIST ON THE NOSOLOGY OF LEONHARD,KARL
    TEICHMANN, G
    [J]. PSYCHOPATHOLOGY, 1990, 23 (4-6) : 267 - 276
  • [54] Test for catatonia with zolpidem
    Thomas, P
    Rascle, C
    Mastain, B
    Maron, M
    Vaiva, G
    [J]. LANCET, 1997, 349 (9053) : 702 - 702
  • [55] Response rate of lorazepam in catatonia: A developing country's perspective
    Tibrewal, Prashant
    Narayanaswamy, Janardhanan
    Zutshi, Amit
    Srinivasaraju, Ravindra
    Math, Suresh Bada
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (08) : 1520 - 1522
  • [56] EFFECTIVENESS AND SAFETY OF ELECTROCONVULSIVE-THERAPY (ECT)
    TUREK, IS
    HANLON, TE
    [J]. JOURNAL OF NERVOUS AND MENTAL DISEASE, 1977, 164 (06) : 419 - 431
  • [57] Lorazepam for chronic catatonia: a randomized, double blind, placebo-controlled cross-over study
    Ungvari, GS
    Chiu, HFK
    Chow, LY
    Lau, BST
    Tang, WK
    [J]. PSYCHOPHARMACOLOGY, 1999, 142 (04) : 393 - 398
  • [58] Urstein, 1912, MANISCH DEPRESSIVES
  • [59] The use of atypical antipsychotics in the treatment of catatonia
    Van Den Eede, F
    Van Hecke, J
    Van Dalfsen, A
    Van den Bossche, B
    Cosyns, P
    Sabbe, BGC
    [J]. EUROPEAN PSYCHIATRY, 2005, 20 (5-6) : 422 - 429
  • [60] The efficacy and safety of ECT in depressed older adults: a literature review
    van der Wurff, FB
    Stek, ML
    Hoogendijk, WJG
    Beekman, ATF
    [J]. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2003, 18 (10) : 894 - 904